Insiders · Profile

Dominy Stephen S.

Chief Scientific Officer at Quince Therapeutics. Filing since 12 Nov 2021. CIK 0001770860

Company
Date
Role
Action
Shares
Amount
Of holding
12 Nov 2021
Chief Scientific Officer
Bought
763
$10.99K
0.1%
1 decision on file.